Active Ingredient: ACETIC ACID, GLACIAL; DESONIDE
Proprietary Name: TRIDESILON
Dosage Form; Route of Administration: SOLUTION/DROPS; OTIC
Strength: 2%;0.05%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017914
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAYER PHARMACEUTICALS CORP
Marketing Status:
Discontinued
Patent and Exclusivity Information
